CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients
Clinical trial NCT00526643 · TERMINATED
Trial details
- NCT number
- NCT00526643
- Sponsor
- National Cancer Institute, Naples
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2012-12-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.